首頁 > 市場調查報告書 > 製藥

OTC 非處方藥

市場調查報告書

商品編碼

1629749

尼古丁口香糖市場按類型、通路和地區分類

Nicotine Gum Market, By Type (2 mg, 4 mg, 6 mg), By Distribution Channel (Supermarkets, Hypermarkets, Pharmacies, Online Stores), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa)

出版日期: 2024年12月20日 | 出版商:

Coherent Market Insights | 英文 120 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計 2024 年全球尼古丁口香糖市場價值將達到 19 億美元，預計 2031 年將達到 31 億美元，2024 年至 2031 年的複合年成長率為 7.2%。

報告範圍		報告詳細資訊
基準年	2023	2024 年的市場規模	19億美元
效能資料	2019 年至 2023 年	預測期	2024 年至 2031 年
預測期間 2024 年至 2031 年複合年成長率：	7.20%	2031 年價值預測	31億美元

圖。

尼古丁口香糖是一種藥用口香糖，可向身體輸送尼古丁，並可作為戒煙輔助劑。尼古丁口香糖的作用是，當你咀嚼它時，它會在你的血液中釋放少量尼古丁。這滿足了使用者對尼古丁的渴求，並減少了戒菸時出現的戒斷症狀。越來越多的人試圖戒菸，推動了全球尼古丁口香糖市場的發展。此外，人們越來越意識到吸菸的健康危害以及尼古丁口香糖在戒菸方面的益處，這也推動了全球對尼古丁口香糖產品的需求。然而，有關尼古丁口香糖銷售和使用的嚴格規定可能會阻礙未來幾年的市場成長。

市場動態：

全球尼古丁口香糖市場的發展受到多種因素的推動，例如越來越多的吸菸者想要戒菸，人們對吸菸健康問題的認知不斷提高，以及口香糖作為菸草替代品的流行和接受度不斷提高。然而，有關尼古丁口香糖產品銷售和行銷的嚴格規定限制了市場的成長。此外，創新尼古丁輸送方法和替代戒菸產品的推出對傳統尼古丁口香糖構成了威脅。領先的公司正在投資研發，以開發技術先進的尼古丁口香糖配方，以提高有效性和便利性。預計這將在不久的將來為市場參與者帶來豐厚的利潤機會。

本研究的主要特點

本報告對全球尼古丁口香糖市場進行了詳細分析，並以 2023 年為基準年，給出了預測期（2024-2031 年）的市場規模和年複合成長率（CAGR%）。

它還強調了各個領域的潛在商機並說明了該市場的有吸引力的投資提案矩陣。

它還提供了對市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景以及主要企業採用的競爭策略的重要見解。

全球尼古丁口香糖市場的主要企業根據公司亮點、產品系列、關鍵亮點、財務表現和策略等參數進行分析。

主要公司包括葛蘭素史克公司、強生公司、諾華消費保健品、ITC 有限公司、西普拉健康有限公司、百利高公司、Fertin Pharma、Alchem International、Revolymer、英美菸草公司和菲利普莫里斯國際公司。

本報告的見解可以幫助負責人和公司經營團隊就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。

全球尼古丁口香糖市場報告迎合了該行業的各個相關人員，例如投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。

相關人員將透過分析全球尼古丁口香糖市場所使用的各種策略矩陣更輕鬆地做出決策。

Report Coverage	Report Details
Base Year:	2023	Market Size in 2024:	US$ 1.90 Bn
Historical Data for:	2019 To 2023	Forecast Period:	2024 To 2031
Forecast Period 2024 to 2031 CAGR:	7.20%	2031 Value Projection:	US$ 3.10 Bn

Nicotine gum is a medicated chewing gum that delivers nicotine to the body and is used as an aid to quit smoking. Nicotine gum works by releasing small doses of nicotine into the bloodstream when chewed. This satisfies the nicotine cravings of the user and reduces the withdrawal symptoms experienced when quitting smoking. The global nicotine gum market is driven by the growing number of individuals attempting to quit the smoking habit. Furthermore, the rising awareness about the health hazards of smoking and the benefits of nicotine gum in cessation is also fueling the demand for nicotine gum products worldwide. However, stringent regulations pertaining to the sale and use of nicotine gum may hinder the market growth in the coming years.

Market Dynamics:

The global nicotine gum market is driven by factors such as the increasing number of smokers wanting to quit smoking, growing awareness about the health issues of smoking, and wider availability and acceptance of chewing gum as an alternative to cigarettes. However, strict regulations regarding the sale and marketing of nicotine gum products restrain the growth of the market. Furthermore, the introduction of innovative nicotine delivery methods and alternative smoking cessation products pose a threat to convention nicotine gums. Major players are investing in R&D to develop technologically advanced nicotine gum formulations for better effectiveness and convenience. This is expected to present lucrative opportunities for market players in the near future.

Key features of the study:

This report provides in-depth analysis of the global nicotine gum market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year.

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.

It profiles key players in the global nicotine gum market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.

Key companies covered as a part of this study include GlaxoSmithKline plc , Johnson & Johnson, Novartis Consumer Health , ITC Limited , Cipla Health Limited, Perrigo Company Plc, Fertin Pharma, Alchem International, Revolymer, British American Tobacco Plc, and Philips Morris International Inc.

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.

The global nicotine gum market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global nicotine gum market.

Market Segmentation

By Type Insights (Revenue, USD Bn, 2019 - 2031)
- 2 mg
- 4 mg
- 6 mg
By Distribution Channel Insights (Revenue, USD Bn, 2019 - 2031)
- Supermarkets
- Hypermarkets
- Pharmacies
- Online Stores
Regional Insights (Revenue, USD Bn, 2019 - 2031)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- GlaxoSmithKline plc
- Johnson & Johnson
- Novartis Consumer Health
- ITC Limited
- Cipla Health Limited
- Perrigo Company Plc
- Fertin Pharma
- Alchem International
- Revolymer
- British American Tobacco Plc
- Philips Morris International Inc

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Nicotine Gum Market, By Type
- Nicotine Gum Market, By Distribution Channel
- Nicotine Gum Market, By Region

3. Market Dynamics, Regulations, And Trends Analysis

Market Dynamics
Impact Analysis
Key Highlights
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
Industry Trends

4. Nicotine Gum Market, By Type, 2024-2031, (USD Bn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
2 mg
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
4 mg
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
6 mg
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

5. Nicotine Gum Market, By Distribution Channel, 2024-2031, (USD Bn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Supermarkets
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Hypermarkets
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Online Stores
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Nicotine Gum Market, By Region, 2024 - 2031, Value (USD Bn)

Introduction
- Market Share (%) Analysis, 2024,2027 & 2031, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2019 - 2031, Value (USD Bn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
  - South Africa
  - North Africa
  - Central Africa

7. Competitive Landscape

GlaxoSmithKline plc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Johnson & Johnson
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Novartis Consumer Health
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
ITC Limited
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Cipla Health Limited
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Perrigo Company Plc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Fertin Pharma
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Alchem International
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Revolymer
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
British American Tobacco Plc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Philips Morris International Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies